Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|22|8|1033-1048
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.22, Iss.8, 2016-02, pp. : 1033-1048
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Immunosuppressants/natalizumab: Glioma?: 4 case reports
Reactions Weekly, Vol. 1, Iss. 1298, 2010-01 ,pp. :
MicroRNA: A Multi-Facet Biological Target for Cancer and Other Diseases
Clinical Cancer Drugs, Vol. 4, Iss. 1, 2017-05 ,pp. :
Targeting miR-21 in glioma: a small RNA with big potential
Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 11, 2010-11 ,pp. :
MicroRNA: Potential Targets for the Development of Novel Drugs?
By Wu Wei
Drugs in R&D, Vol. 10, Iss. 1, 2010-05 ,pp. :